Promopharm stands out in a falling market
Tuesday, May 19, 2026 delivered a sharp contrast on the Casablanca Stock Exchange today: Promopharm surged 5.9% to MAD 1,346, the best performance on the board, even as the MASI index fell 1.0% to 18,263.97 points. In a session where 40 stocks declined and only 16 advanced, that move clearly set the pharmaceutical name apart as one of the market’s few pockets of strength.
The rally matters even more because it came against a difficult macro backdrop for Moroccan equities exposed to imported inputs. The USD/MAD rose 3.21% to 9.2307 and the EUR/MAD gained 2.96% to 10.706, while Brent crude remained elevated at $111.0 per barrel, despite a 1.0% daily pullback. For the Morocco stock market, that mix points to a heavier import bill, higher cost pressure for industrial companies, and tighter margin assumptions for businesses reliant on foreign-currency purchases.
Key figures
- Promopharm: +5.9% at MAD 1,346
- MASI: -1.0% at 18,263.97
- 40 decliners versus